Traditional Culture Encyclopedia - Traditional stories - Dear all, a question for you, how to kill H. pylori bacteria

Dear all, a question for you, how to kill H. pylori bacteria

The preferred treatment regimen for the removal of H. pylori is a triple combination of a proton pump inhibitor (PPI) or bismuth and two antibiotics. The main measure is the selection of highly effective anti-Helicobacter pylori medication by a specialist, the regular treatment dosage and course of treatment, in order to prevent the recurrence of H. pylori after treatment. Experts believe that without regular triple or quadruple anti-H. pylori treatment, it is unlikely that the infection can be cured by dietary modifications. Prevention of infection is the most economical and effective way. In addition to personal hygiene, meal portioning and sterilization of medical equipment should be promoted (at the same time, medical staff should also be more aware of self-protection). In addition, progress has been made in the development of a vaccine for H. pylori, and it is believed that a vaccine for H. pylori will become an effective means of preventing and controlling H. pylori infection in the near future.

Opinion:

The eradication rate of Helicobacter pylori (HP) was evaluated by one-week triple therapy based on proton pump inhibitor (PPI), bismuth (CBS), and H+ receptor antagonist (H2RA), respectively. METHODS: 65 patients with HP (+) were randomized into three groups, all of which were given one-week triple therapy for HP eradication.Group A consisted of PPI 20mg + amoxicillin 1.0g + metronidazole 0.4g all Bid, Group B consisted of CBS 120mg + clarithromycin 0.25g + metronidazole 0.4g all Bid, and Group C consisted of H2RA (tamaglumic acid or famotidine 20mg - ranitidine 150mg)Bid+Amoxicillin 1.0+Metronidazole 0.4g all Bid,and review ^14C-UBT after stopping the drug for at least 4 weeks.RESULTS: The eradication rate of group A was 85.7% (18/21); group B was 87.5% (21/14); and group C was 80% (16/20). CONCLUSION: A one-week triple regimen of PPI-based and bismuth-based regimens containing clarithromycin resulted in similar eradication rates but did not reach 90%.